- TheStreet.com•9 hours ago
AstraZeneca's Lynparza significantly delayed the recurrence of tumors in patients with ovarian cancer compared to a placebo, according to results from a phase III study announced by the company Wednesday....
- optionMONSTER•9 hours ago
Traders apparently believe that AstraZeneca may continue its recent downtrend. OptionMonster's tracking program detected the purchase of 5,000 November 27 puts for $0.30 yesterday. There was no open interest ...
- Business Insider•5 days ago
Pharmacists around the country are agitated. For years they've been watching their customers...
AstraZeneca PLC (AZN.L)
LSE - LSE Delayed Price. Currency in GBp
|Bid||4,700.00 x 6100|
|Ask||5,100.00 x 13000|
|Day's Range||4,724.50 - 4,818.00|
|52wk Range||3,680.00 - 5,505.00|
|1y Target Est||N/A|
|P/E Ratio (ttm)||27.30|
|Avg Vol (3m)||2,578,997|
|Dividend & Yield||N/A (N/A)|